JL14002 (ranibizumab biosimilar)
/ Jecho Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 06, 2026
A Study to Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)
(clinicaltrials.gov)
- P3 | N=443 | Completed | Sponsor: Jecho Biopharmaceuticals Co., Ltd.
New P3 trial • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders • Wet Age-related Macular Degeneration
1 to 1
Of
1
Go to page
1